Preclinical News and Research

RSS
Head injury and dementia - Alzheimer’s connection

Head injury and dementia - Alzheimer’s connection

IHD blood test for Alzheimer's disease yields 83% sensitivity and 82% specificity

IHD blood test for Alzheimer's disease yields 83% sensitivity and 82% specificity

NSVascular signs exclusive license with UCLA for Thin-Film Nitinol technology

NSVascular signs exclusive license with UCLA for Thin-Film Nitinol technology

Study: IL-2 monotherapy not effective as maintenance therapy for acute myeloid leukemia

Study: IL-2 monotherapy not effective as maintenance therapy for acute myeloid leukemia

Higher rates of falls can occur very early in Alzheimer's disease

Higher rates of falls can occur very early in Alzheimer's disease

European Commission Framework 7 programme awards €3 million grant to Enigma Diagnostics

European Commission Framework 7 programme awards €3 million grant to Enigma Diagnostics

Champions Oncology revenue increases 41% to $6.9 million for fiscal 2011

Champions Oncology revenue increases 41% to $6.9 million for fiscal 2011

UTHealth enrolls first patient in new stem cell therapy trial for ischemic stroke

UTHealth enrolls first patient in new stem cell therapy trial for ischemic stroke

NeoStem to acquire Amorcyte

NeoStem to acquire Amorcyte

Two promising projects focus on new treatments for cystic fibrosis

Two promising projects focus on new treatments for cystic fibrosis

Positive data from Inovio's VGX-3400X Phase I study against H5N1 influenza

Positive data from Inovio's VGX-3400X Phase I study against H5N1 influenza

Proteus receives U.S. patent for ingestible digital devices

Proteus receives U.S. patent for ingestible digital devices

Celprogen develops neuronal stem cells to treat Alzheimer's

Celprogen develops neuronal stem cells to treat Alzheimer's

Cerulean initiates CRLX101 Phase 2 trial in non-small cell lung cancer

Cerulean initiates CRLX101 Phase 2 trial in non-small cell lung cancer

Arena reports APD811 Phase 1 trial results against pulmonary arterial hypertension

Arena reports APD811 Phase 1 trial results against pulmonary arterial hypertension

IGR, IPSEN sign 3 year medical oncology agreement

IGR, IPSEN sign 3 year medical oncology agreement

NIAID awards $14 million a year for new HIV research

NIAID awards $14 million a year for new HIV research

iBio successfully produces human plasma proteins using proprietary technology

iBio successfully produces human plasma proteins using proprietary technology

Alnylam seeks CTA clearance to initiate ALN-PCS Phase I clinical trial for severe hypercholesterolemia

Alnylam seeks CTA clearance to initiate ALN-PCS Phase I clinical trial for severe hypercholesterolemia

Generex announces convertible preferred stock securities purchase agreement

Generex announces convertible preferred stock securities purchase agreement

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.